Adherium Launches Hailie Solution Direct-to-Consumer in the U.S. for Better Asthma and COPD Management

Adherium (ASX:ADR), a leading digital health platform that focuses on improving medication adherence and patient outcomes, today officially launched the Hailie solution in the U.S., following its recent Food and Drug Administration (FDA) 510(k) over-the-counter clearance to enable sales direct to consumers. The Hailie solution helps patients with asthma and COPD access better care through a seamless digital experience that includes a smartphone app, available on both iOS and Android, and a sensor that attaches to patient’s prescription inhaler medication.

As quoted in the press release:

Adherium believes health technology should be simple to use and it has strived to make the Hailie™ solution effortless for anybody managing chronic respiratory conditions like asthma and COPD. The Hailie™ solution is designed to help patients achieve better adherence by providing people who live with asthma or COPD with the tools to manage their condition and empowering them to take control of their health. It does this by tracking medication use and reminding the user with helpful nudges when it’s time to take doses. The Hailie solution can also provide visibility of medication use and adherence to parents and caregivers.

“We’re extremely excited to announce the availability of the full Hailie™ solution in the U.S.,” said Arik Anderson, CEO of Adherium. “Individuals and families with asthma and COPD can now access a solution that encompasses the world’s most clinically proven asthma and COPD medication adherence platform, cleverly packaged into the simplest interface. Hailie is the culmination of 15 years of accelerating research and development and is focused on the premise that if we are to turn the corner on treating chronic conditions, we have to make managing them second nature. Today, through advances in technology, the power of real-time feedback, and data science we can cross that last mile in achieving better health – putting medicine to work in the proving ground of everyday life.”

Click here to read the full press release.